NO20042478L - Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter - Google Patents
Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenterInfo
- Publication number
- NO20042478L NO20042478L NO20042478A NO20042478A NO20042478L NO 20042478 L NO20042478 L NO 20042478L NO 20042478 A NO20042478 A NO 20042478A NO 20042478 A NO20042478 A NO 20042478A NO 20042478 L NO20042478 L NO 20042478L
- Authority
- NO
- Norway
- Prior art keywords
- drugs
- preparation
- sulfonamide derivatives
- sulfonamide
- derivatives
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940124530 sulfonamide Drugs 0.000 title 1
- 150000003456 sulfonamides Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Manufacturing & Machinery (AREA)
- Ceramic Engineering (AREA)
- Psychiatry (AREA)
- Structural Engineering (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200102517A ES2187300B1 (es) | 2001-11-14 | 2001-11-14 | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
PCT/ES2002/000518 WO2003042175A1 (es) | 2001-11-14 | 2002-11-08 | Derivados de sulfonamidas, su preparación y su aplicación como medicamentos |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20042478L true NO20042478L (no) | 2004-08-12 |
Family
ID=8499446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20042478A NO20042478L (no) | 2001-11-14 | 2004-06-14 | Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter |
Country Status (34)
Country | Link |
---|---|
US (4) | US7105515B2 (de) |
EP (2) | EP1445252B1 (de) |
JP (2) | JP4416505B2 (de) |
KR (1) | KR20040071685A (de) |
CN (1) | CN1271052C (de) |
AR (1) | AR037288A1 (de) |
AT (2) | ATE319684T1 (de) |
BR (1) | BR0214243A (de) |
CA (1) | CA2466965C (de) |
CO (1) | CO5590895A2 (de) |
CY (1) | CY1105362T1 (de) |
DE (2) | DE60232029D1 (de) |
DK (1) | DK1445252T3 (de) |
EC (1) | ECSP045105A (de) |
ES (4) | ES2187300B1 (de) |
HK (1) | HK1070053A1 (de) |
HR (1) | HRP20040429B1 (de) |
HU (1) | HUP0402317A2 (de) |
IL (2) | IL161885A0 (de) |
IS (2) | IS7263A (de) |
MA (1) | MA27093A1 (de) |
MX (1) | MXPA04004601A (de) |
NO (1) | NO20042478L (de) |
NZ (2) | NZ533136A (de) |
PL (1) | PL373894A1 (de) |
PT (2) | PT1445252E (de) |
RS (1) | RS41104A (de) |
RU (2) | RU2293082C2 (de) |
SG (1) | SG146442A1 (de) |
SI (1) | SI1445252T1 (de) |
TW (1) | TWI275585B (de) |
UA (1) | UA78252C2 (de) |
WO (1) | WO2003042175A1 (de) |
ZA (1) | ZA200404073B (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2187300B1 (es) * | 2001-11-14 | 2004-06-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
RU2005138147A (ru) * | 2003-05-09 | 2007-06-27 | Лабораториос Дель Др. Эстеве С.А. (Es) | Применение сульфонамидных производных для изготовления лекарственного средства, предназначенного для профилактики и/или лечения нарушений потребления пищи |
ES2222830B1 (es) | 2003-07-30 | 2006-02-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 7-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
ES2222832B1 (es) * | 2003-07-30 | 2006-02-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
ES2228268B1 (es) * | 2003-07-30 | 2006-07-01 | Laboratorios Del Dr. Esteve, S.A. | Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6. |
ES2222827B1 (es) * | 2003-07-30 | 2006-03-01 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 5-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
ES2228267B1 (es) * | 2003-07-30 | 2006-07-01 | Laboratorios Del Dr. Esteve, S.A. | Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6. |
ES2222829B1 (es) * | 2003-07-30 | 2006-03-01 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 4-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
SE0303480D0 (sv) * | 2003-12-19 | 2003-12-19 | Biovitrum Ab | Benzofuranes |
AU2004312229B2 (en) * | 2004-01-02 | 2010-05-20 | Suven Life Sciences Limited | Novel Indeno[2,1a]indenes and isoindolo[2,1-a]indoles |
ES2246721B1 (es) * | 2004-08-10 | 2007-03-16 | Laboratorios Del Dr. Esteve, S.A. | Compuestos indolicos sustituidos, su preparacion y su uso como medicamentos. |
EP1632491A1 (de) * | 2004-08-30 | 2006-03-08 | Laboratorios Del Dr. Esteve, S.A. | Substituierte indol-verbindungen und deren verwendung als modulatoren des 5-ht6 rezeptors |
PL1883451T3 (pl) | 2005-04-13 | 2011-05-31 | Neuraxon Inc | Podstawione związki indolowe mające aktywność hamowania NOS |
JP5026690B2 (ja) * | 2005-11-21 | 2012-09-12 | 株式会社ジャパンディスプレイイースト | 表示装置 |
AU2007208109B2 (en) * | 2006-01-24 | 2012-08-23 | Eli Lilly And Company | Indole sulfonamide modulators of progesterone receptors |
EP1837332A1 (de) * | 2006-03-23 | 2007-09-26 | Laboratorios Del Dr. Esteve, S.A. | Substituierte Tetrahydroisochinoline, deren Herstellung und Verwendung als Medikamente |
ZA200809659B (en) * | 2006-04-13 | 2010-03-31 | Neuraxon Inc | 1,5 and 3,6-substituted indole compounds having NOS inhibitory activity |
EP1902733A1 (de) * | 2006-09-19 | 2008-03-26 | Laboratorios Del Dr. Esteve, S.A. | Kombination von einem NMDA Rezeptorligand und einer Verbindung mit 5-HT6 Rezeptor-Affinität |
EP1953153A1 (de) * | 2007-01-31 | 2008-08-06 | Laboratorios del Dr. Esteve S.A. | Heterocyclyl-substituierte Sulfonamide für die Behandlung von Wahrnehmungsstörungen bzw. Ernährungserkrankungen |
EP1953141A1 (de) * | 2007-01-31 | 2008-08-06 | Laboratorios del Dr. Esteve S.A. | Aryl-substituierte Sulfonamide für die Behandlung von Wahrnehmungsstörungen oder Ernährungskrankheiten |
EP2018861A1 (de) * | 2007-07-26 | 2009-01-28 | Laboratorios del Dr. Esteve S.A. | 5HT6-Liganden wie Sulfonamidederivaten bei wirkstoffinduzierter Gewichtszunahme |
DE602007012080D1 (de) * | 2007-08-01 | 2011-03-03 | Esteve Labor Dr | Kombination von mindestens zwei 5-HT6-Liganden |
EP2036888A1 (de) * | 2007-09-17 | 2009-03-18 | Laboratorios del Dr. Esteve S.A. | Naphthyl-substituierte Sulfonamide |
CN101910157B (zh) * | 2007-11-16 | 2014-05-07 | 纽尔亚商股份有限公司 | 吲哚化合物和治疗内脏痛的方法 |
AU2008321353A1 (en) * | 2007-11-16 | 2009-05-22 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods for treating visceral pain |
US20090131503A1 (en) * | 2007-11-16 | 2009-05-21 | Annedi Subhash C | 3,5 - substituted indole compounds having nos and norepinephrine reuptake inhibitory activity |
EP2116547A1 (de) | 2008-05-09 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | Substituierte n-Imidazo[2,1-b]thiazol-5-sulfonamid-Derivative als 5-TH6-Liganden |
EP2116546A1 (de) | 2008-05-09 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | Substituierte N-Phenyl-2,3-dihydroimidazo[2,1-b]thiazol-5-sulfonamid-Derivative als 5-HT6-Liganden |
MX2016001446A (es) * | 2013-08-02 | 2016-05-05 | Pfizer | Inhibidores de heterobicicloaril rorc2 y metodos de uso de los mismos. |
MA40759A (fr) | 2014-09-26 | 2017-08-01 | Pfizer | Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3472870A (en) * | 1966-08-29 | 1969-10-14 | Mead Johnson & Co | Sulfonamidotryptamines |
US5578612A (en) * | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
NZ305166A (en) * | 1995-03-20 | 1998-12-23 | Lilly Co Eli | 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles; preparation and medicaments |
US5962473A (en) * | 1996-08-16 | 1999-10-05 | Eli Lilly And Company | Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F |
EP0875513A1 (de) * | 1997-04-14 | 1998-11-04 | Eli Lilly And Company | Substituierte heteroaromatische 5-HT1F Agoniste |
US6380201B1 (en) * | 1997-08-05 | 2002-04-30 | Eli Lilly And Company | Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists |
ES2187300B1 (es) * | 2001-11-14 | 2004-06-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
-
2001
- 2001-11-14 ES ES200102517A patent/ES2187300B1/es not_active Expired - Fee Related
-
2002
- 2002-08-11 UA UA20040604587A patent/UA78252C2/uk unknown
- 2002-11-08 ES ES02785439T patent/ES2259387T3/es not_active Expired - Lifetime
- 2002-11-08 DE DE60232029T patent/DE60232029D1/de not_active Expired - Lifetime
- 2002-11-08 AT AT02785439T patent/ATE319684T1/de active
- 2002-11-08 EP EP02785439A patent/EP1445252B1/de not_active Expired - Lifetime
- 2002-11-08 DK DK02785439T patent/DK1445252T3/da active
- 2002-11-08 RS YU41104A patent/RS41104A/sr unknown
- 2002-11-08 SG SG200602676-9A patent/SG146442A1/en unknown
- 2002-11-08 AT AT05021228T patent/ATE428694T1/de active
- 2002-11-08 IL IL16188502A patent/IL161885A0/xx unknown
- 2002-11-08 EP EP05021228A patent/EP1666462B1/de not_active Expired - Lifetime
- 2002-11-08 DE DE60209779T patent/DE60209779T2/de not_active Expired - Lifetime
- 2002-11-08 WO PCT/ES2002/000518 patent/WO2003042175A1/es active Application Filing
- 2002-11-08 RU RU2004117850/04A patent/RU2293082C2/ru not_active IP Right Cessation
- 2002-11-08 PL PL02373894A patent/PL373894A1/xx not_active Application Discontinuation
- 2002-11-08 AR ARP020104303A patent/AR037288A1/es not_active Application Discontinuation
- 2002-11-08 CN CNB028240804A patent/CN1271052C/zh not_active Expired - Fee Related
- 2002-11-08 PT PT02785439T patent/PT1445252E/pt unknown
- 2002-11-08 ES ES05021228T patent/ES2322068T3/es not_active Expired - Lifetime
- 2002-11-08 SI SI200230302T patent/SI1445252T1/sl unknown
- 2002-11-08 BR BR0214243-0A patent/BR0214243A/pt not_active IP Right Cessation
- 2002-11-08 NZ NZ533136A patent/NZ533136A/en unknown
- 2002-11-08 PT PT05021228T patent/PT1666462E/pt unknown
- 2002-11-08 KR KR10-2004-7007155A patent/KR20040071685A/ko not_active Application Discontinuation
- 2002-11-08 NZ NZ543393A patent/NZ543393A/en unknown
- 2002-11-08 MX MXPA04004601A patent/MXPA04004601A/es active IP Right Grant
- 2002-11-08 JP JP2003544012A patent/JP4416505B2/ja not_active Expired - Fee Related
- 2002-11-08 CA CA2466965A patent/CA2466965C/en not_active Expired - Fee Related
- 2002-11-08 HU HU0402317A patent/HUP0402317A2/hu unknown
- 2002-11-11 TW TW091132989A patent/TWI275585B/zh not_active IP Right Cessation
- 2002-11-13 US US10/293,206 patent/US7105515B2/en not_active Expired - Fee Related
-
2004
- 2004-05-06 ES ES200401084A patent/ES2249129B2/es not_active Expired - Fee Related
- 2004-05-13 IS IS7263A patent/IS7263A/is unknown
- 2004-05-13 EC EC2004005105A patent/ECSP045105A/es unknown
- 2004-05-14 HR HR20040429A patent/HRP20040429B1/xx not_active IP Right Cessation
- 2004-05-25 ZA ZA200404073A patent/ZA200404073B/en unknown
- 2004-05-26 CO CO04048713A patent/CO5590895A2/es not_active Application Discontinuation
- 2004-06-07 MA MA27723A patent/MA27093A1/fr unknown
- 2004-06-14 NO NO20042478A patent/NO20042478L/no not_active Application Discontinuation
- 2004-09-03 US US10/933,951 patent/US7176200B2/en not_active Expired - Fee Related
-
2005
- 2005-02-05 HK HK05101004A patent/HK1070053A1/xx not_active IP Right Cessation
- 2005-11-22 RU RU2005136355/04A patent/RU2005136355A/ru not_active Application Discontinuation
-
2006
- 2006-06-02 CY CY20061100709T patent/CY1105362T1/el unknown
- 2006-07-17 US US11/487,745 patent/US7498328B2/en not_active Expired - Fee Related
-
2007
- 2007-02-16 US US11/707,571 patent/US7452881B2/en not_active Expired - Fee Related
- 2007-12-05 IS IS8698A patent/IS8698A/is unknown
-
2008
- 2008-08-04 IL IL193234A patent/IL193234A0/en unknown
-
2009
- 2009-09-29 JP JP2009223711A patent/JP5132649B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1445252T3 (da) | Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter | |
NO20035298D0 (no) | CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler | |
DK1368349T3 (da) | Xanthinderivater, deres fremstilling og deres anvendelse som lægemidler | |
NO20020811D0 (no) | Sulfonylkarboksamidderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler | |
NO20025879L (no) | Acylfenylureaderivater, fremgangsmåter for fremstilling derav og deres anvendelse som legemiddel | |
DK1083171T3 (da) | Pyrazolinderivater, deres fremstilling og anvendelse som medikamenter | |
DK1373191T3 (da) | Acylerede indanylaminer og deres anvendelse som lægemidler | |
NO20025357D0 (no) | Antranylamider og deres anvendelse som legemidler | |
DK1419150T3 (da) | 1-Phenylsulfonyl-1,3-dihydro-2H-indol-2-on-derivater, deres fremstilling og deres terapeutiske anvendelse | |
NO20033566D0 (no) | Acylerte 6,7,8,9-tetrehydro-5H-benzocykloheptenyl-aminer og deres anvendelse som farmasöytiske midler | |
DK1095025T3 (da) | Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler | |
NO20011503L (no) | Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, deres fremstilling og anvendelse som anorektiske legemidler | |
NO20030302L (no) | Nye heteroarylderivater og deres anvendelse som medikamenter | |
NO20042635L (no) | 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin | |
NO20005146D0 (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
NO20044322L (no) | Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament | |
DK1370550T3 (da) | Quinolylpropylpiperidinderivater, deres fremstilling og præparater indeholdende dem | |
DK1387838T3 (da) | Cyanoanthranylamid-derivater og deres anvendelse som lægemidler | |
NO20031838D0 (no) | Benzokazinonderivater, deres fremstilling og anvendelse | |
DK1525193T3 (da) | Acylaminothiazolderivater, deres fremstilling og deres terapeutiske anvendelse | |
NO20040210L (no) | Fenylacetamido-tiazolderivater, fremgangsmate for deres fremstilling og deres anvendelse som antitumormidler | |
NO20024107L (no) | Tienopyridin derivater, deres fremstilling og anvendelse | |
DK1373249T3 (da) | Imidazolidinderivater, deres fremstilling og deres anvendelse som anti-inflammatorisk middel | |
NO20033965L (no) | Caloporosidderivater, fremgangsmåte for deres fremstilling og deres anvendelse | |
NO20005549L (no) | Substituerte sulfonylcyanamider, deres fremstilling og anvendelse som medikament |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |